Dublin, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The "Global Synthetic Hormones Market: Focus on Product Type, Application, Route…
The Global Glaucoma Treatment Market Size was valued at USD 6.4 Billion in 2022 and the Worldwide Glaucoma Treatment Market…
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…
Companies covered in this study are Novartis, AstraZeneca, Merck & Co., Inc, Bristol-Myers Squibb, Pfizer, Eli Lilly and Company, Gilead…
This heavily sold-off pharma stock is a bargain, so is it time to buy?…
Frankfurt (Reuters) - Das Europäische Patentamt hat im Patentstreit zwischen den beiden Corona-Impfstoffherstellern BioNTech und Moderna ein mRNA-Patent des US-Biotechkonzerns…
…
Ende August hatte die US-Biotech-Firma Moderna das Mainzer Unternehmen Biontech und dessen US-Partner Pfizer verklagt. Das Urteil fiel nun zugunsten…
Texas AG sues Pfizer over quality-control lapses in kids ADHD drug…
…
Pfizer CEO Albert Bourla says the drug maker is hoping to develop an oral anti-obesity drug that can rival Ozempic.…
Allschwil, 20. November 2023 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel,…
^Allschwil, 20. November 2023 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel,…
^Allschwil, 20. November 2023Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutischesUnternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zuhelfen,…
Weiterhin gute Cresemba® (Isavuconazol)-Umsätze in der Region Asien-Pazifik und China lösen dritte Meilensteinzahlung von Pfizer in diesem Jahr für diese…
Allschwil, Switzerland, November 20, 2023…
…
Viatris is the old generic drug company Mylan, acquired by Pfizer and merged with its Upjohn division. The stock has…
Both companies share prices have slipped recently.…
Both companies share prices have slipped recently.…
Though Pfizers (PFE) revenues from COVID products are declining sharply, the launch of some key non-COVID products in 2023 is…
Despite little prescriber differentiation between the JAKs, including satisfaction and manufacturer perceptions, Olumiant is projected to maintain a significant market…
Pfizer Inc (NYSE:PFE) has said it will lay off more than half of its employees at a UK-based scientific research centre…
…
…
Pfizer is cutting 500 jobs at its Sandwich, Kent site in the U.K. as part of a cost-cutting effort, Sky…
Pfizer to cut 500 jobs at Kent site - Sky News…
One is growing now, and the other will grow soon.…
Todays Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Walmart Inc. (WMT) and…
Excluding a brief early 2020 plunge, Pfizer shares are now trading at their lowest level since 2016.…
Prior to launch, prescribers estimate that TNF inhibitors are likely to bear the greatest brunt of increased adoption of the…
Am Freitag noch im Rally-Modus, zum Wochenauftakt an der Seitenlinie: Die US-Investoren üben sich am Montag in Zurückhaltung. In der…
Analysts said upcoming data on Pfizers obesity pill, danuglipron, will be crucial to how competitive the company can be against…
Calgary (www.aktiencheck.de, Anzeige)
Einschätzung
Strong OutperformerKurszieleKursziel 12M: 9 USD
Kurschance: 223%
Kursziel 24M: 13,50 USD
Kurschance: 384%StammdatenISIN: CA98420Q3061
WKN: A3EUNZ
Ticker: ANUA
TSXV: XRTX.V
NASDAQ: XRTXKursdatenKurs: 2,79 USD
52W Hoch:…
…
By John Vandermosten, CFA
NASDAQ:ACHV
READ THE FULL ACHV RESEARCH REPORT
Achieve Life Sciences, Inc. (NASDAQ:ACHV) reported third quarter 2023 results in a…
…
Pfizer, Eli Lilly, General Motors and Tesla have been highlighted in this Earnings Trends article.…
Pfizer works to speed production of key penicillin as officials see "unacceptable American crisis," underscoring need for rapid testing and…
…
By John Vandermosten, CFA
NYSE:PLX
READ THE FULL PLX RESEARCH REPORT
Third Quarter 2023 Financial and Operational Review
Protalix Biotherapeutics, Inc. (NYSE:PLX) announced 3Q:23…
…
MAINZ (dpa-AFX) - Das Biotechnologieunternehmen Biontech hat wie andere Hersteller mit dem schrumpfenden Absatz von Covid-19-Impfstoffen zu kämpfen. Die…
BioNTech SE’s stock BNTX rallied premarket after the company posted a surprise profit for the third quarter and revenue that…
Wien (www.aktiencheck.de) - Pfizer-Aktienanalyse von der Raiffeisen Bank International AG:
Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), rät in…
Derzeit gibt es in der Pharma- und Biotechbranche große Verlierer unter den Unternehmen, welche die größten Profiteure der Corona Krise…
Tokyo, Japan and Cambridge, UK, 06 November 2023 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) has…
The old adage is that magazine covers are a jinx. That’s particularly true with The Economist but Barron’s has had…
London (www.aktiencheck.de) - Rating-Update:
Die Analysten von Barclays stufen die Aktie von Pfizer Inc. (ISIN: US7170811035, WKN: 852009, Ticker-Symbol: PFE, NYSE-Symbol:…
…